S-3 EX-FILING FEES 0001788028 N/A N/A 0001788028 1 2026-10-13 2026-10-13 0001788028 2026-10-13 2026-10-13 iso4217:USD xbrli:pure xbrli:shares

Ex-Filing Fees

CALCULATION OF FILING FEE TABLES

S-3

Jasper Therapeutics, Inc.

Table 1: Newly Registered and Carry Forward Securities

                                           
Line Item Type   Security Type   Security Class Title   Notes   Fee Calculation
Rule		   Amount Registered   Proposed Maximum Offering
Price Per Unit		   Maximum Aggregate Offering Price   Fee Rate   Amount of Registration Fee
                                           
Newly Registered Securities
Fees to be Paid   Equity   Common Stock, par value $0.0001 per share   (1)   Other   284,013,011   $ 0.56   $ 159,047,286.16   0.000087   $ 13,837.11
                                           
Total Offering Amounts:   $ 159,047,286.16         13,837.11
Total Fees Previously Paid:               0.00
Total Fee Offsets:               0.00
Net Fee Due:             $ 13,837.11

__________________________________________
Offering Note(s)

(1) Pursuant to Rule 416(a) under the Securities Act of 1933, as amended (the “Securities Act”), this registration statement also covers any additional securities that may be offered or issued in connection with any stock dividend, stock split, recapitalization or similar transaction.

Pursuant to Rule 457(c) under the Securities Act, and solely for the purpose of calculating the registration fee, the proposed maximum offering price per share is $0.56, which is the average of the high and low prices of the registrant's common stock, par value $0.0001 per share (“Common Stock”) on October 9, 2026, on the Nasdaq Capital Market.

Consists of 284,013,011 shares of Common Stock issuable upon the conversion of 4,655,951 shares of the Company’s non-voting convertible preferred stock.